Successful treatment of severe juvenile microscopic polyangiitis with rituximab

Clinical Rheumatology

Volumn 28, Issue 8, 2009, Pages 997-999

  Brunner, Juergen ^a   Freund, M ^a   Prelog, M ^a   Binder, E ^a   Sailer Hoeck, M ^a   Jungraithmayr, T ^a   Huemer, C ^b   Sergi, C ^c   Zimmerhackl, L B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Hospital Bregenz   (Austria)

^c MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Children; Microscopic polyangiitis; Rituximab; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; CD19 ANTIGEN; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADOLESCENT; ANTIBODY TITER; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULONEPHRITIS; HEMATURIA; HEMOPTYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LIVEDO RETICULARIS; LOW DRUG DOSE; LUNG DISEASE; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SINGLE DRUG DOSE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOLOGIC FACTORS; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 67849121333     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1177-0     Document Type: Article

References (15)

1. Jayne D (2008) Challenges in the management of microscopic polyangiitis: past, present and future. Curr Opin Rheumatol 20:3-9
2. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936-941
3. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222-227
4. Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G, Kostic M, Markovic-Lipkovski J, Nikolic M, Spasojevic B (2006) Childhood microscopic polyangiitis associated with MPO-ANCA. Pediatr Nephrol 21:46-53
5. Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, Dougados M, Ferraccioli G, Jaeger U, Klareskog L, Kvien TK, Martin-Mola E, Pavelka K (2007) Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 66:143-150
6. Walsh M, Jayne D (2008) Targeting the B cell in vasculitis. Pediatr Nephrol
7. Patel AM, Lehman TJ (2008) Rituximab for severe refractory pediatric Wegener granulomatosis. J Clin Rheumatol 14:278-280
8. Tamura N, Matsudaira R, Hirashima M, Ikeda M, Tajima M, Nawata M, Morimoto S, Kaneda K, Kobayashi S, Hashimoto H, Takasaki Y (2007) Two cases of refractory Wegener's granulomatosis successfully treated with rituximab. Intern Med 46:409-414
9. Minami R, Miyamura T, Watanabe H, Takahama S, Yamamoto M, Suematsu E (2007) [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab]. Nihon Rinsho Meneki.Gakkai Kaishi 30:133-138
10. Smith KG, Jones RB, Burns SM, Jayne DR (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum 54:2970-2982
11. Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257:540-548
12. Stasi R, Stipa E, Del PG, Amadori S, Newland AC, Provan D (2006) Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45:1432-1436
13. Edelbauer M, Jungraithmayr T, Zimmerhackl LB (2005) Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: Case report. Pediatr Nephrol 20:811-813
14. Willems M, Haddad E, Niaudet P, Kone-Paut I, Bensman A, Cochat P, Deschenes G, Fakhouri F, Leblanc T, Llanas B, Loirat C, Pillet P, Ranchin B, Salomon R, Ulinski T, Bader-Meunier B (2006) Rituximab therapy for childhood-onset systemic lupus erythematosus. J.Pediatr 148:623-627
15. El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP (2007) Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr 150:376-382